Federal Register / Vol. 75, No. 220 / Tuesday, November 16, 2010 / Notices 70013 

Reduction Act of 1995 (44 U.S.C. 3501– 

3520). The collections of information in 

part 900 have been approved under 

OMB control number 0910–0309. 

V. Comments 

Interested persons may submit to the 

Division of Dockets Management (see 

ADDRESSES), either electronic or written 

comments regarding this document. It is 

only necessary to send one set of 

comments. It is no longer necessary to 

send two copies of mailed comments. 

Identify comments with the docket 

number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

Dated: November 10, 2010. 

Nancy K. Stade, 

Deputy Director for Policy, Center for Devices 

and Radiological Health. 

[FR Doc. 2010–28762 Filed 11–15–10; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–1344–CN] 

RIN 0938–AP89 

Medicare Program; Inpatient 

Rehabilitation Facility Prospective 

Payment System for Federal Fiscal 

Year 2011; Correction 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Correction notice. 

SUMMARY: This document corrects a 

technical error that appeared in the 

notice published in the July 22, 2010 

Federal Register entitled, ‘‘Inpatient 

Rehabilitation Facility Prospective 

Payment System for Federal Fiscal Year 

2011.’’ 

DATES: Effective Date. This correction is 

effective for IRF discharges occurring on 

or after October 1, 2010 and on or before 

September 30, 2011. 

FOR FURTHER INFORMATION CONTACT: 

Susanne Seagrave, (410) 786–0044. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In FR Doc. 2010–17621 of July 22, 

2010 (75 FR 42836), there was a 

technical error that we are identifying 

and correcting in the ‘‘Correction of 

Errors’’ section below. The provisions in 

this correction notice are effective as if 

they had been included in the document 

published July 22, 2010. Accordingly, 

the corrections are effective October 1, 

2010. 

II. Summary of Errors 

In the July 22, 2010 notice (75 FR 

42836), we applied our established 

formula for calculating the national 

cost-to-charge (CCR) ceiling. Using that 

formula, the national CCR ceiling 

should have been calculated to be 1.61. 

It was inadvertently listed on page 

42856 as 2.94 due to a calculation error. 

Thus, we are correcting page 42856 to 

reflect the correct result of the 

application of the established formula. 

The corrected national CCR ceiling is 

1.61 for FY 2011. 

III. Correction of Errors 

In FR Doc. 2010—17621 of July 22, 

2010 (75 FR 42836), make the following 

corrections: 

1. On page 42856, in column 1, in line 

23 from the top of the page, the value 

‘‘2.94’’ is corrected to read ‘‘1.61.’’ 

2. On page 42856, in column 1, in line 

25 from the top of the page, the value 

‘‘2.94’’ is corrected to read ‘‘1.61.’’ 

IV. Waiver of Proposed Rulemaking 

and Delayed Effective Date 

We ordinarily publish a notice of 

proposed rulemaking in the Federal 

Register to provide a period for public 

comment before the provisions of a rule 

take effect in accordance with section 

553(b) of the Administrative Procedure 

Act (APA) (5 U.S.C. 553(b)). We also 

ordinarily provide a 30-day delay in the 

effective date of the provisions of a rule 

in accordance with section 553(d) of the 

APA (5 U.S.C. 553(d)). However, we can 

waive both notice and comment 

procedures and the 30-day delay in 

effective date if the Secretary finds, for 

good cause, that such procedures are 

impracticable, unnecessary, or contrary 

to the public interest, and incorporates 

a statement of the finding and the 

reasons into the notice. 

The policies and payment 

methodology expressed in the FY 2011 

IRF PPS notice (75 FR 42836) have 

previously been subjected to notice and 

comment procedures. This correction 

notice merely provides a technical 

correction to the FY 2011 notice, and 

does not make substantive changes to 

the policies or payment methodologies 

that were expressed in that notice. 

Therefore, we find it unnecessary to 

undertake further notice and comment 

procedures with respect to this 

correction notice. We also believe that it 

is in the public interest (and would be 

contrary to the public interest to do 

otherwise) to waive notice and comment 

procedures and the 30-day delay in 

effective date for this notice. This 

correction notice is intended to ensure 

that the FY 2011 IRF PPS notice 

accurately reflects the payment 

methodologies and policies expressed in 

the notice, and that the correct 

information is made available to the 

public. Therefore, we find good cause to 

waive notice and comment procedures 

and the 30-day delay in the effective 

date for this correction notice. 

(Catalog of Federal Domestic Assistance 

Program No. 93.773, Medicare—Hospital 

Insurance; and Program No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: November 9, 2010. 

Dawn L. Smalls, 

Executive Secretary to the Department. 

[FR Doc. 2010–28814 Filed 11–15–10; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

President’s Cancer Panel. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: President’s Cancer 

Panel. 

Date: December 14, 2010. 

Time: 8 a.m. to 4:45 p.m. 

Agenda: The Future of Cancer Research: 

Accelerating Scientific Innovation. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, 6C10, Bethesda, 

MD 20892. 

Contact Person: Abby B. Sandler, PhD, 

Executive Secretary, Chief, Institute Review 

Office, Office of the Director, 6116 Executive 

Blvd., Suite 220, MSC 8349, National Cancer 

Institute, NIH, Bethesda, MD 20892–8349, 

(301) 451–9399, sandlera@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

mstockstill on DSKH9S0YB1PROD with NOTICES